PMCTPharmaCountry
    Home

Regulatory Updates

FDA, EMA, TGA and global regulatory developments

#ointment ×

UPDATED
Regulatory Updates
Aug 30, 2026•1 min read
FDA Discontinues FLUTEX Topical Ointment (ANDA087377)
FDA records indicate the FLUTEX topical ointment (0.1% Triamcinolone Acetoinide) by IVAX PHARMS is discontinued, with original ANDA approval in 1988 and a labeling supplement in 1992.
1
UPDATED
Regulatory Updates
Aug 27, 2026•1 min read
FDA Announces Discontinued Ophthalmic Ointment DEXAIR (ANDA088071)
The FDA’s ANDA088071 filing shows that DEXAIR ophthalmic ointment, containing 0.05% dexamethasone sodium phosphate, is marked discontinued by sponsor PharmaFair.